Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Kowalska, Justyna D; Kubicka, Joanna; Siwak, Ewa; Pulik, Piotr; Firlag-Burkacka, Ewa; Horban, Andrzej

Kowalska, Justyna D; Kubicka, Joanna; Siwak, Ewa; Pulik, Piotr; Firlag-Burkacka, Ewa; Horban, Andrzej.

Affiliation

Kowalska JD; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland ; Department for Adult's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Kubicka J; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
Siwak E; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
Pulik P; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
Firlag-Burkacka E; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
Horban A; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland ; Department for Adult's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.

AIDS Res Ther ; 13: 2, 2016.

Article de En | MEDLINE | ID: mdl-26744599

Sujet(s)
Mots clés

Aging; Antiretroviral therapy; Late presenters; Pharmacovigilance; Toxicity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Agents antiVIH / Substitution de médicament Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: AIDS Res Ther Année: 2016 Type de document: Article Pays d'affiliation: Pologne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google